Kaplan–Meier survival estimates showed that low GAS5 expression in breast cancer tissues was associated with poor disease free survival (DFS) (P = 0.015, log-rank test) and overall survival (OS) (P = 0.048, log-rank test) (Figure 2e and 2f). This evidence concerns the gene GAS5 and breast cancer.